Table 1. mRNA expression of V-ATPase subunits of the V1 domain (A-H) and the V0 domain (a, c, c’’, d, e) is shown in human leukemic cell lines related to non-tumor primary human PBMCs.
V-ATPase subunit | S-Jurkat | CEM | K562 | HL60 |
---|---|---|---|---|
ATP6V1A | 0.70±0.07 | 1.41±0.11 | 2.83±0.47 | 0.70±0.05 |
ATP6V1B1 | 0.43±0.16 | 1.16±0.60 | 1.24±1.13 | 0.36±0.19 |
ATP6V1B2 | 0.52±0.07 | 0.63±0.10 | 0.88±0.10 | 0.68±0.12 |
ATP6V1C1 | 0.90±0.06 | 0.93±0.09 | 2.59±0.22 | 0.83±0.09 |
ATP6V1C2 | 0.79±0.21 | 0.48±0.11 | 0.75±0.15 | 34.28±15.71 |
ATP6V1D | 0.96±0.01 | 1.19±0.14 | 1.87±0.05 | 0.24±0.01 |
ATP6V1E1 | 1.00±0.05 | 0.97±0.01 | 3.43±0.44 | 0.89±0.06 |
ATP6V1E2 | 0.51±0.05 | 0.37±0.03 | 0.65±0.06 | 0.17±0.01 |
ATP6V1F | 1.12±0.27 | 1.64±0.34 | 5.27±0.39 | 1.00±0.06 |
ATP6V1G1 | 1.00±0.17 | 1.06±0.06 | 1.61±0.13 | 0.60±0.04 |
ATP6V1G2 | 0.12±0.03 | 1.00±0.14 | 0.11±0.03 | 0.06±0.01 |
ATP6V1G3 | 0.18±0.07 | 0.69±0.25 | 0.10±0.00 | 0.11±0.04 |
ATP6V1H | 0.85±0.04 | 1.16±0.06 | 2.32±0.08 | 0.66±0.04 |
ATP6V0A1 | 0.48±0.01 | 1.07±0.06 | 10.67±0.87 | 0.60±0.05 |
ATP6V0A2 | 0.78±0.03 | 0.66±0.21 | 1.55±0.10 | 0.30±0.04 |
ATP6V0A3 | 0.01±0.00 | 0.11±0.01 | 0.37±0.24 | 0.68±0.07 |
ATP6V0A4 | 0.82±0.31 | 1.46±0.23 | 1.26±0.71 | 0.83±0.28 |
ATP6V0B | 1.53±0.12 | 1.47±0.14 | 4.78±0.53 | 1.46±0.49 |
ATP6V0C | 0.67±0.06 | 0.81±0.07 | 2.39±0.36 | 0.90±0.10 |
ATP6V0D1 | 0.38±0.03 | 0.44±0.04 | 1.26±0.12 | 0.86±0.09 |
ATP6V0D2 | 0.10±0.04 | 0.19±0.17 | 9.09±4.84 | 18.38±5.61 |
ATP6V0E1 | 0.34±0.08 | 0.72±0.16 | 0.84±0.03 | 0.62±0.04 |
ATP6V0E2 | 1.97±0.08 | 2.62±0.15 | 0.54±0.05 | 0.07±0.01 |